As the Vice President of Genetic Innovation at Machaon Diagnostics Inc., Jamey Kain is at the forefront of advancing molecular diagnostics, particularly in the realm of coagulation and complement testing. With a robust background in biological research, Jamey leverages his expertise in molecular genetics and...
As the Vice President of Genetic Innovation at Machaon Diagnostics Inc., Jamey Kain is at the forefront of advancing molecular diagnostics, particularly in the realm of coagulation and complement testing. With a robust background in biological research, Jamey leverages his expertise in molecular genetics and synthetic biology to develop next-generation sequencing genetic panels that facilitate the rapid diagnosis of rare diseases. His innovative approach has led to the design and validation of a groundbreaking sequencing-based test for atypical hemolytic uremic syndrome, achieving an unprecedented turnaround time of just 48 hours—setting a new standard in the industry.
Jamey’s commitment to pushing the boundaries of clinical molecular testing is further exemplified by his development of a clinical SARS-CoV-2 RT-LAMP assay, which provides same-day results, significantly enhancing the speed and efficiency of COVID-19 diagnostics. His work not only underscores his proficiency in polymerase chain reaction (PCR) techniques but also highlights his ability to integrate cutting-edge technologies into practical applications that address urgent public health needs.
With a PhD focused on the molecular, neural, and genetic origins of personality in Drosophila, Jamey brings a unique perspective to the field of genetic innovation. His foundational knowledge in evolutionary biology and entomology enriches his understanding of genetic mechanisms, allowing him to approach complex biological questions with creativity and rigor. As he continues to lead key projects at Machaon Diagnostics, Jamey remains dedicated to transforming the landscape of genetic testing, ultimately improving patient outcomes through timely and accurate diagnostics.